Teradyne, Inc. filings document an operating company with common stock traded on Nasdaq under TER and businesses in automated test equipment and advanced robotics. Form 8-K reports cover quarterly operating and financial results across Semiconductor Test, Product Test, and Robotics, along with material events such as annual meeting vote results and executive-transition or compensation arrangements.
Proxy materials describe board elections, advisory compensation votes, auditor ratification, executive compensation, equity-award reporting, and related governance matters. The filings also provide capital-structure details, including Teradyne's common stock class, and formal exhibits tied to earnings releases and other disclosure events.
Teradyne, Inc. director Marilyn Matz sold 400 shares of common stock on October 21, 2026, at $350 per share. The transaction was effected pursuant to a sales plan adopted February 13, 2026, intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Her reported direct holdings following the sale were 12,641 shares.
Teradyne, Inc. director Marilyn Matz reported an intended sale of 400 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of $140,000.00 and an approximate sale date of October 21, 2026. The shares are listed as compensation from restricted-stock vesting on May 9, 2024. The notice also lists four sales in the preceding three months: 1,200 shares on August 17, 800 on September 15, 400 on September 17, and 800 on October 15, 2026.
Teradyne, Inc. (TER) President and CEO Gregory Stephen Smith sold 4,000 shares of common stock on October 15, 2026, at $341.28 per share. He directly held 104,495 shares following the sale. The transaction was effected under a sales plan adopted February 12, 2026, intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
Teradyne, Inc. director Marilyn Matz sold 800 shares of common stock on October 15, 2026, at $341.28 per share, in a transaction described as a sale in the open market or a private transaction. The sale was made under a sales plan adopted February 13, 2026, intended to comply with Rule 10b5-1. Her reported direct holdings following the sale were 13,041 shares.
Gregory Stephen Smith, identified as an officer and director of Teradyne, Inc. (TER), reported a proposed sale of 4,000 common shares through Fidelity Brokerage Services LLC on October 15, 2026, with an aggregate market value of $1,365,120. The notice also lists three prior sales of 4,000 shares each, dated July 15, August 17, and September 15, 2026.
Teradyne, Inc. director Marilyn Matz reported a proposed sale of 800 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of $273,024.00 and a proposed sale date of October 15, 2026. The notice lists the shares as acquired through restricted-stock vesting: 44 shares on May 7, 2021, and 756 shares on May 9, 2024. It lists 156,340,750 shares outstanding.
Teradyne, Inc. director Mercedes Johnson sold 167 shares of common stock on October 1, 2026, at $402.90 per share under a sales plan adopted March 4, 2026, which was intended to comply with Rule 10b5-1. After the sale, Johnson directly held 6,197 shares, while The Mercedes Johnson Trust held 1,876 shares.
Teradyne, Inc. (TER) director Mercedes Johnson reported a proposed sale of 167 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of $67,284.30 and an approximate sale date of October 1, 2026. The notice lists 156,340,750 shares outstanding. It also reports Johnson sold 167 shares on July 1, 166 on August 3, and 167 on September 1, 2026.
Teradyne, Inc. director Peter Herweck acquired 77 deferred stock units (DSUs) on September 24, 2026, through deferral of quarterly cash compensation. He acquired 4 additional DSUs on September 25, 2026, after electing to receive dividends on DSUs as additional DSUs rather than cash. The DSUs are generally settled one-for-one in Common Stock within 90 days after his service as a non-employee director ends.
Teradyne, Inc. director Paul J. Tufano acquired 141 deferred stock units on September 24, 2026, by deferring quarterly cash compensation, and 19 additional units on September 25, 2026, through his election to receive dividends paid on DSUs as additional DSUs instead of cash. The units generally settle one-for-one in Common Stock within 90 days after a non-employee director no longer serves in that capacity.